Reinsurance Group of America (RGA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
The annual shareholders' meeting is scheduled for May 20, 2026, with a record date of March 23, 2026, and approximately 65.5 million shares eligible to vote.
Key business items include director elections, a say-on-pay vote, approval of an amended Employee Stock Purchase Plan (ESPP), and auditor ratification.
The company reported strong 2025 results: net income per diluted share of $17.69 and adjusted operating income per share of $24.42, with a return on equity of 9.7% and adjusted operating ROE of 15.7%.
Senior management changes include new appointments and retirements in key executive roles.
Voting matters and shareholder proposals
Shareholders will vote on electing all directors for a one-year term, an advisory say-on-pay vote, approval of the amended ESPP, and ratification of Deloitte & Touche as independent auditor.
Board recommends voting FOR all proposals.
All proposals require a majority of shares present or represented by proxy to pass.
Board of directors and corporate governance
The board consists of 12 members, 11 of whom are independent, with an independent chair and all committees comprised entirely of independent directors.
Annual director elections, majority voting, and proxy access are in place; no supermajority or poison pill provisions.
Board committees include Audit, Cybersecurity and Technology, Human Capital and Compensation, Investment, Nominating and Governance, and Risk, each with defined oversight responsibilities.
Regular board and committee assessments are conducted, including external reviews every three years.
Director compensation is reviewed biennially, with 2026 equity grants increased by $10,000.
Latest events from Reinsurance Group of America
- Record earnings, strong premium growth, and new share repurchase authorization.RGA
Q4 20256 Feb 2026 - Innovation, global scale, and disciplined capital management drive strong growth and returns.RGA
Investor Day 20243 Feb 2026 - Adjusted operating EPS hit $5.48, ROE 15.3%, and $307M deployed into in-force transactions.RGA
Q2 20242 Feb 2026 - Record adjusted operating income and ROE, with strong premium growth and capital deployment.RGA
Q3 202417 Jan 2026 - Record operating income, capital deployment, and higher ROE targets highlight strong growth.RGA
Q4 20248 Jan 2026 - RGA to reinsure $32B of life liabilities, deploying $1.5B and targeting $200M annual pre-tax income.RGA
Investor Update7 Jan 2026 - Board recommends approval of all proposals amid record results and strong governance.RGA
Proxy Filing1 Dec 2025 - Q1 2025 EPS $5.66, ROE 15%, net income $288M; $32B reinsurance deal pending.RGA
Q1 202529 Nov 2025 - Record EPS, robust capital deployment, and a $12B reinsurance deal drive strong results.RGA
Q3 20251 Nov 2025